What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to officially furnish Boston Scientific Corporation's press release announcing its first quarter 2023 financial results. It provides investors with a direct link to the company's latest performance information.

Where can I find the actual financial results for Q1 2023?

The detailed financial results for the first quarter ended March 31, 2023, are located in the press release furnished as Exhibit 99.1 to this 8-K filing.

Does this filing contain updated financial guidance from Boston Scientific?

This 8-K filing itself does not contain guidance. Investors should refer to the furnished press release (Exhibit 99.1) for any updated financial guidance or outlook provided by Boston Scientific for the remainder of 2023.

What is the significance of the information not being 'filed' under Section 18?

The statement that the information is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934 means that the company is not subject to the strict liabilities associated with that section for the contents of the furnished press release. However, investors should still consider the information provided as material.

BSX 8-K: Earnings & Results

Summary

Boston Scientific Corporation (BSX) has filed an 8-K report on April 25, 2023, furnishing a press release dated April 26, 2023, which details its financial results for the first quarter ended March 31, 2023. This filing serves as the primary vehicle for investors to access the company's latest performance metrics and financial condition. The key takeaway for investors is the release of the Q1 2023 earnings. While the 8-K itself does not contain the detailed financial figures, it directs readers to the accompanying press release (Exhibit 99.1) for this crucial information. Investors should review this press release to understand the company's revenue, profitability, and any forward-looking guidance provided for the upcoming quarters and fiscal year.

Key Highlights

1Boston Scientific Corp (BSX) filed an 8-K on April 25, 2023.
2The filing includes a press release announcing Q1 2023 financial results.
3The press release is dated April 26, 2023, and is furnished as Exhibit 99.1.
4Investors can find Q1 2023 operational and financial performance details within the press release.
5This 8-K is a standard disclosure for earnings announcements.
6The information is not deemed 'filed' for Section 18 of the Exchange Act, limiting liability.

BOSTON SCIENTIFIC CORP 8-K Report, Financial Results (Apr 26, 2023)

Summary

Key Highlights

Frequently Asked Questions